Effect of probiotic Lactobacillus strains in children with atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 2, 2003, Pages 389-395

  Rosenfeldt, Vibeke ^a,b   Benfeldt, Eva ^c   Nielsen, Susanne Dam ^b   Michaelsen, Kim Fleischer ^a   Jeppesen, Dorthe Lisbeth ^b   Valerius, Niels Henrik ^b   Paerregaard, Anders ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atopic dermatitis; Clinical trial; Inflammation; Probiotics

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PLACEBO; PROBIOTIC AGENT;

ADOLESCENT; ANTIBODY DETECTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ECZEMA; FREEZE DRYING; HUMAN; LACTOBACILLUS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME;

LACTOBACILLUS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS;

EID: 0037327049     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.389     Document Type: Article

References (26)

1. Fuller R. Probiotics in human medicine. Gut 1991;32:439-42.
2. Kalliomaeki M, Salminen S, Arvilomi H, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease. A randomised placebo-controlled trial. Lancet 2001;357:1076-9.
3. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604-10.
4. Majamaa H, Isolauri E. Probiotics. A novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
5. Shida K, Makino K, Morishita A. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998;115:278-87.
6. Nexmann Jacobsen C, Rosenfeldt Nielsen V, Heyford A, Møller PL, Michaelsen KF, Pærregaard A, et al. Screening of probiotic activities of 47 strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999;65:4949-56.
7. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Møller PL, Pedersen P, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 2002;21:411-6.
8. Rosenfeldt V, Michaelsen F, Jakobsen, Larsen CM, Møller PL, Tvede M, et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of non-hospitalized children attending day care centers. Pediatr Infect Dis J 2002;21:417-9.
9. Venge P, Roxin LE, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 1977;37:331-5.
10. Williams HC, Burney PGJ, Hay RJ, Archer CB, Shipley MJ, Hunter JJA, et al. The UK Working Party's diagnostic criteria for atopic dermatitis. Br J Dermatol 1994;131:383-96.
11. Stadler JF. Severity scoring of atopic dermatitis. The SCORAD index. Consensus Report of the European Task Force on Atopic dermatitis. Dermatology 1993;186:23-31.
12. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sørensen TU, Dreves AM, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001;98:398-404.
13. Schødt T. Size of materials for clinical trials. How many patients are required? Ugeskr Laeger 1986;148:2333-5.
14. Halbert A, William L, Morelli JG. Atopic dermatitis: is it an allergic disease? J Am Acad Dermatol 1995;33:1008-18.
15. Wold AE. The hygiene hypothesis revised. Is the rising frequency of allergy due to changes in the intestinal flora? Allergy 1999;83:20-5.
16. Majamaa H, Isolauri E. Evaluation of the gut mucosal barrier. Evidence of increased antigen transfer in children with atopic dermatitis. J Allergy Clin Immunol 1996;97:985-90.
17. Caffarelli C, Cavagni G, Deriu F, Zanotti P, Atherton D. Gastrointestinal symptoms in atopic dermatitis. Arch Dis Child 1998;78:230-4.
18. Caffarelli C, Deriu FM, Terzi V, dé Anglis G, Atherton D. Gastrointestinal symptoms in patients with asthma. Arch Dis Child 2000;83:131-5.
19. Kalimo K, Lammintausta K, Klemi P. Mast cells and IgE in intestinal mucosa in adult atopic dermatitis patients. Br J Dermatol 1988;119:101-4.
20. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-91.
21. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvillomi H. Lactobacillus casei strain GG reverses intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993;105:1643-50.
22. Czech W, Krutmann J, Schöpf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-5.
23. Niggerman B, Beyer K, Wahm U. The role of eosinophils and eosinophil cationic protein in monitoring oral challenge tests in children with food-sensitive atopic dermatitis. J Allergy Clin Immunol 1994;94:963-71.
24. Sütas Y, Hurme M, Isolauri E. Down-regulation of anti-CD-3 antibody-induced IL-4 production by hovine caseins hydrolysed by Lactobacillus GG-derived enzymes [letter]. Scand J Immunol 1996;43:687-9.
25. Pessi T, Sütas U, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000;30:1804-8.
26. Tang M, Kemp A, Varigos G. IL-4 and interferon-γ production in children with atopic disease. Clin Exp Allergy 1993;92:20-4.